Women have higher tau, especially in setting of elevated Aβ
Apr 05, 2023
Later age at menopause and hormone therapy non-use also were associated with higher regional tau.
Alzheimer’s research, treatments prioritized in 2 bills taken up by Congress
By
Kimberly Bonvissuto
Feb 06, 2023
Two bipartisan bills prioritizing Alzheimer’s research and supporting scientists in the development of treatments for the disease were reintroduced in Congress last week.
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
5α-reductase inhibitors linked to depression, but not dementia
Dec 29, 2022
The magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant.
Study explores impact of FDA approval of aducanumab on trial participation
Dec 06, 2022
Individuals who were independently aware of the FDA decision demonstrated a reduced willingness to participate.
More news for Tuesday, Dec. 6
By
Kimberly Bonvissuto
Dec 06, 2022
LeadingAge Minnesota Foundation invests $400,000 in 24 workforce grants … Merger targets strengthening assisted living … FCC opens applications for $5M internet pilot program for affordable senior...
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
RecallCue wins Gold for dementia clock
By
Foster Stubbs
Nov 11, 2022
Gold in the Tech Partner of the Year category of the 2022 McKnight’s Excellence in Technology Awards goes to RecallCue, an internet-connected day clock meant to combat the effects of dementia.
BMI declines seen seven years before cognitive impairment diagnosis
Nov 02, 2022
However, after diagnosis, BMI declines at the same pace in people who develop or do not develop dementia.